4-O′-methylhonokiol protects from alcohol/carbon tetrachloride-induced liver injury in mice
- 8 July 2017
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 95 (10) , 1077-1089
Abstract
Alcoholic liver disease (ALD) is a leading cause of liver cirrhosis, liver cancer, and related mortality. The endocannabinoid system contributes to the devKeywords
Funding Information
- The Swiss Foundation for Alcohol Research (SSA FSRA) (242)
This publication has 50 references indexed in Scilit:
- Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?Journal of Neuroinflammation, 2012
- Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo modelsJournal of Neuroinflammation, 2012
- The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openingsBritish Journal of Pharmacology, 2011
- Is lipid signaling through cannabinoid 2 receptors part of a protective system?Progress in Lipid Research, 2011
- Endocannabinoids in liver diseaseHepatology, 2010
- Beneficial Paracrine Effects of Cannabinoid Receptor 2 on Liver Injury and Regeneration†Hepatology, 2010
- Role of the Endocannabinoid System in Alcoholic Liver DiseaseDigestive Diseases, 2010
- Animal Models of Alcoholic Liver DiseaseDigestive Diseases, 2010
- Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosisJournal of Leukocyte Biology, 2007
- Effects of magnolol (5,5′-diallyl-2,2′-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto–Kakizaki ratsLife Sciences, 2007